Search Results

Business

Bionik Laboratories Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations

Bionik Laboratories Corp., continues to grow its partnership with Lifepoint Health, announcing its four new installations of the InMotion® ARM robotic device in Phoenix, Arizona, Sacramento, California, Brownsburg, Indiana, and Louisville, Kentucky, to deliver quality stroke recovery care.

June 15, 2023

·

6 min read

Genetown

Bionik Laboratories’ InMotion® Robotic Devices on Display at the Korea International Medical & Hospital Equipment Show (KIMES)

Bionik Laboratories Corp. today announced its InMotion® Robots will be on display at the Korea International Medical & Hospital Equipment Show (KIMES) from March 23 – March 26, 2023.

March 23, 2023

·

6 min read

Genetown

Bionik Laboratories to Present at the Q4 Virtual Investor Summit

Bionik Laboratories Corp. will present at the 2022 Investor Summit Q4 Micro-Cap Conference.

November 7, 2022

·

4 min read

Genetown

BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference

BIONIK Laboratories Corp. today announced that Rich Russo, Chief Financial Officer and Interim Chief Executive Officer, will be presenting a corporate overview and meeting with institutional investors at the Q3 Virtual Investor Summit.

August 9, 2022

·

1 min read

Genetown

BIONIK Laboratories to Present at National Investment Banking Association Conference

BIONIK Laboratories Corp. announced that Richard Russo, Interim CEO, will present a corporate overview at the National Investment Banking Association conference on September 8, 2022.

September 1, 2022

·

4 min read

Business

Bionik Laboratories Appoints Richard Russo, Jr. as Chief Executive Officer and Dan Gonsalves as Chief Financial Officer

Bionik Laboratories Corp . today announced the appointments of Richard Russo, Jr. as Chief Executive Officer and President, who previously served as Chief Financial Officer.

October 13, 2022

·

7 min read

Protect Pharmaceutical Corp. Issues Corporate Update

Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: “July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the fiscal year of 2023 is near completion.

July 1, 2024

·

4 min read

Policy

MustGrow Biologics Corp. Announces Results of Shareholder Meeting

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), is pleased to announce the results of its 2024 annual meeting of shareholders (the “Meeting”) held on June 27, 2024.

June 28, 2024

·

4 min read

NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan(R)

NX Development Corp. (NXDC) is pleased to announce a significant milestone.

June 21, 2024

·

1 min read

Business

BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results

BIONIK Laboratories Corp. (OTCPink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported financial results for the fourth quarter and fiscal year 2022, ended March 31, 2022.

June 9, 2022

·

13 min read